Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Cambridgeshire based Founder operating in the Life Science space. If you think a Founder is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Hannah Sore
Founder and CEO of PharmEnable
Follow Hannah Sore:
About PharmEnable: PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.
Paulo Garcia
CEO & Co-Founder of Kytopen
Dr. Paulo A. Garcia co-invented the Flowfect™ technology while he was a Research Scientist at MIT. He is currently leading the development and commercialization efforts of the proprietary cell engineering platform for therapeutic and biotechnology applications.
Follow Paulo Garcia:
About Kytopen: Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Eoin McKinney
Chief Scientific Officer & Co-Founder of PredictImmune
Eoin is a Wellcome-Beit intermediate Research Fellow in the Department of Medicine at the University of Cambridge and an honorary consultant in nephrology and transplantation in Cambridge University NHS hospitals Foundation Trust. He obtained a first-class degree in pre-clinical medicine from Keble College, Oxford University in 1999 and graduated in clinical medicine with honours from Edinburgh University in 2002. His primary interest is the use of systems immunology approaches to translate high throughput analyses of autoimmune disease datasets into clinical practice.
Follow Eoin McKinney:
About PredictImmune: Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
Kenneth Smith
Co-Founder & Chief Medical Officer of PredictImmune
Professor Ken Smith is Professor of Medicine and Head of the Department of Medicine at the University of Cambridge. He trained in nephrology (FRACP, FRCP) and clinical immunology (FRCPA) and completed a PhD at the WEHI in Melbourne. His laboratory runs a translational programme in autoimmune disease (particularly inflammatory bowel disease, vasculitis and SLE) that has led to the discovery of a novel prognosis-predicting biomarker currently in clinical trials and the identification of genes and pathways involved in disease pathogenesis.
Follow Kenneth Smith:
About PredictImmune: Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
Paul Lyons
Vice President of Platform Delivery & Co-Founder of PredictImmune
Paul is a Principal Research Associate in the Department of Medicine at the University of Cambridge. He has over 25 years of experience in molecular and cellular biology including Senior Scientist positions in the Dept. Medical Genetics, University of Cambridge, Dept. Surgery, University of Oxford and the Rosalind Franklin Centre for Genomics Research. His primary research interest is the application of high throughput genomic approaches to better understand the genetic and molecular basis of autoimmune disease.
Follow Paul Lyons:
About PredictImmune: Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
Tuomas Knowles
Founder and Chief Scientific Officer of Fluidic Analytics
Professor Tuomas Knowles holds a personal Professorship in the Department of Chemistry at the University of Cambridge and is also a Fellow of St John’s College Cambridge. Tuomas received his PhD in Physics from the University of Cambridge, and has held positions in Engineering in Cambridge and Harvard University before returning to Cambridge as a University Lecturer in 2010, Reader in 2013 and then Professor in 2015. His current research interests are focused on using physical approaches to study the self-assembly of protein molecules both in the context of disease and for the synthesis of novel functional biomaterials. Tuomas has received a number of distinguished awards, most recently from the Royal Society of Chemistry, the Newman Foundation and the European Research Council, and has co-authored over 60 peer-reviewed scientific articles.
Follow Tuomas Knowles:
About Fluidic Analytics, Transition Bio: Fluidic Analytics designs, develops and manufactures tools that seek to revolutionise the way proteins are characterised.
Magdeline Pokar
Founder, Managing Director of Asia Research News
Maggie is the managing director of Asia Research News, overseeing all aspects of this innovative startup.
Follow Magdeline Pokar:
About Asia Research News: Asia Research News connects researchers with international media, policy makers, fellow collaborators and the science-hungry public.
Niluka Satharasinghe
Co-Founder & CTO of Sparrho
Follow Niluka Satharasinghe:
About Sparrho: Sparrho lead the world in democratising science using augmented intelligence.
Gordon McInroy
Founder and CTO of Nuclera
Follow Gordon McInroy:
About Nuclera: Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.
Stewart Newlove
Founder of Antibodies.com
Stewart Newlove is the Founder of Antibodies.
Follow Stewart Newlove:
About Antibodies.com: Antibodies.com is a leading supplier of protein research tools. Discover more from our range of distinct antibodies, proteins, and assays.
